Figure 1.
Molecular structures of OXi6196 and phosphate prodrug OXi6197, as well as related molecules exhibiting vascular disrupting activity. Exposure of prodrug OXi6197 to alkaline phosphatase leads to rapid release of OXi6196 [27].
Molecular structures of OXi6196 and phosphate prodrug OXi6197, as well as related molecules exhibiting vascular disrupting activity. Exposure of prodrug OXi6197 to alkaline phosphatase leads to rapid release of OXi6196 [27].